Comera Life Sciences (CMRA) Short Interest Ratio & Short Volume

Short interest is the volume of Comera Life Sciences shares that have been sold short but have not yet been closed out or covered. As of November 15th, traders have sold 138,100 shares of CMRA short. 2.38% of Comera Life Sciences' shares are currently sold short. Learn More on Comera Life Sciences' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CMRA shares currently have a short interest ratio of 1.0. Learn More on Comera Life Sciences's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.38% of Comera Life Sciences' floating shares are currently sold short.

Comera Life Sciences saw a drop in short interest in November. As of November 15th, there was short interest totaling 138,100 shares, a drop of 51.0% from the previous total of 281,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Comera Life Sciences currently has issued a total of 30,740,000 shares. Some of Comera Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Comera Life Sciences currently has a public float of 5,800,000 shares.

2.38% of Comera Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Comera Life Sciences: Sunshine Biopharma, Inc. (7.32%), GRI Bio, Inc. (0.61%), Panbela Therapeutics, Inc. (2.36%), Biodexa Pharmaceuticals Plc (14.70%), NeuBase Therapeutics, Inc. (0.81%), 180 Life Sciences Corp. (3.30%), SciSparc Ltd. (21.38%), InMed Pharmaceuticals Inc. (1.89%), Evelo Biosciences, Inc. (2.11%), PainReform Ltd. (2.95%),

As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($7.24 billion), T-Mobile US, Inc. ($4.02 billion), Charter Communications, Inc. ($3.72 billion), Occidental Petroleum Co. ($2.80 billion), Lululemon Athletica Inc. ($2.48 billion), Coinbase Global, Inc. ($2.38 billion), Tractor Supply ($2.35 billion), Rivian Automotive, Inc. ($1.79 billion), Royal Caribbean Cruises Ltd. ($1.73 billion), and Moderna, Inc. ($1.71 billion). View all of the most shorted stocks.

Short selling CMRA is an investing strategy that aims to generate trading profit from Comera Life Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Comera Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CMRA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CMRA, twice per month. The most recent reporting period available is November, 15 2023.